Clinical Trial Update: Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer [Phase 2, Phase 3]

View source ↗

Summary

This document describes a clinical trial evaluating an adjuvant schedule of docetaxel, an anthracycline, and cyclophosphamide for breast cancer in Phase 2 and P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anthracycline (anthracycline)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Fudan University | Conditions: Breast Neoplasms, Adjuvant | Phase 2, Phase 3 | Status: UNKNOWN